Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver Fibrosis
Aim. An overview of current pharmacotherapy for non-alcoholic steatohepatitis (NASH)-associated liver fibrosis.Key points. In current clinical recommendations, therapeutic measures in non-alcoholic fatty liver disease should include lifestyle change, body weight normalisation, NASH-associated liver...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Artigo |
| Sprache: | Russo |
| Veröffentlicht: |
Gastro LLC
2022-01-01
|
| Schriftenreihe: | Российский журнал гастроэнтерологии, гепатологии, колопроктологии |
| Schlagworte: | |
| Online-Zugang: | https://www.gastro-j.ru/jour/article/view/646 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|